Analysis of clonality using X-linked polymorphisms in a patient with multiple myeloma and myelofibrosis

American Journal of Hematology

Volumn 59, Issue 1, 1998, Pages 79-82

  Stevenson, James P ^a,c   Schwarting, Roland ^b   Schuster, Stephen J ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

Clonality; Multiple myeloma; Myelofibrosis; X chromosome inactivation

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; MELPHALAN; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CELL CLONE; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTOSIS; MULTIPLE MYELOMA; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; PLASMA CELL; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

CLONE CELLS; FEMALE; HUMANS; LINKAGE (GENETICS); MIDDLE AGED; MULTIPLE MYELOMA; MYELOFIBROSIS; POLYMORPHISM, GENETIC; X CHROMOSOME;

EID: 0031827332     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199809)59:1<79::AID-AJH15>3.0.CO;2-X     Document Type: Article

References (14)

1. Anger A, Janssen JWG, Schrezenmeier H, Hehlmann R, Heimpel H, Bartram CR: Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia 4:258-261, 1990.
2. Phelan J, Liu Y, Go RCP, Prchal JF, Prchal JT: Rapid determination of clonality and genotype distribution by transcriptional polymorphism detection of two closely linked X chromosome genes, G6PD and p55. Blood 88(Suppl. 1):1904a, 1996.
3. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG: Langerhan's cell histiocytosis (Histiocytosis X): A clonal proliferative disease. N Engl J Med 331:154-160, 1994.
4. Brody JI, Beizer LH, Schwartz S: Multiple myeloma and the myeloproliferative syndromes. Am J Med 36:315-319, 1964.
5. Coughlin C, Greenwald ES, Schraft WC, Grossman S: Myelofibrosis associated with multiple myeloma. Arch Int Med 138:590-592, 1978.
6. Vandermolen L, Rice L, Lynch EC: Plasma cell dyscrasia with marrow fibrosis. Am J Med 79:297-302, 1985.
7. Humphrey CA, Morris TCM: The intimate relationship of myelofibrosis and myeloma: Effect of therapy. Br J Haematol 73:269-270, 1989.
8. Meerkin D, Ashkenazi Y, Gottschalk-Sabag S, Hershko C: Plasma cell dyscrasia with marrow fibrosis: A reversible syndrome mimicking agnogenic myeloid metaplasia. Cancer 73:625-628, 1994.
9. McCluggage WG, Jones FGC, Hull D, Bharucha H: Sclerosing IgA multiple myeloma. Acta Haematol 94:98-101, 1995.
10. Lewis MJ, Oelbaum MH, Coleman M, Allen S: An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. Br J Haematol 63:173-180, 1986.
11. Nagai M, Iwamoto M, Marumoto K, Fujita M, Takahara J: Granulocyte-colony stimulating factor concentrations in a patient with plasma cell dyscrasia and features of chronic neutrophilic leukaemia. J Clin Pathol 49:858-860, 1996.
12. Standen GR, Steers FJ, Jones L: Clonality of chronic neutrophilic leukaemia associated with myeloma: Analysis using the X-linked probe M27β. J Clin Pathol 46:297-298, 1992.
13. Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC: Transforming growth factor-beta1: Differential effects on multiple myeloma versus normal B cells. Blood 87:1928-1938, 1996.
14. Portier M, Zhang XG, Ursule E, Lees D, Jourdan M, Bataille R, Klein B: Cytokine gene expression in human multiple myeloma. Br J Haematol 85:514-520, 1993.